Fast and cost-effective SARS-CoV-2 variant detection using Oxford Nanopore full-length spike gene sequencing.
Oxford Nanopore Technologies
SARS-CoV-2
spike gene
surveillance
Journal
Microbial genomics
ISSN: 2057-5858
Titre abrégé: Microb Genom
Pays: England
ID NLM: 101671820
Informations de publication
Date de publication:
05 2023
05 2023
Historique:
medline:
22
5
2023
pubmed:
18
5
2023
entrez:
18
5
2023
Statut:
ppublish
Résumé
Most biologically relevant and diagnostic mutations in the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) genome have been identified in the S gene through global genomic surveillance efforts. However, large-scale whole-genome sequencing (WGS) is still challenging in developing countries due to higher costs, reagent delays and limited infrastructure. Consequently, only a small fraction of SARS-CoV-2 samples are characterized through WGS in these regions. Here, we present a complete workflow consisting of a fast library preparation protocol based on tiled amplification of the S gene, followed by a PCR barcoding step and sequencing using Nanopore platforms. This protocol facilitates fast and cost-effective identification of main variants of concern and mutational surveillance of the S gene. By applying this protocol, report time and overall costs for SARS-CoV-2 variant detection could be reduced, contributing to improved genomic surveillance programmes, particularly in low-income regions.
Identifiants
pubmed: 37200071
doi: 10.1099/mgen.0.001013
pmc: PMC10272875
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Références
Nature. 2020 Mar;579(7798):270-273
pubmed: 32015507
Lancet. 2020 Feb 22;395(10224):565-574
pubmed: 32007145
Nat Commun. 2022 Nov 16;13(1):7003
pubmed: 36385137
Bioinformatics. 2014 Nov 15;30(22):3276-8
pubmed: 25095880
Nature. 2021 May;593(7858):176-177
pubmed: 33953391
Infect Genet Evol. 2021 Aug;92:104910
pubmed: 33975021
Front Med (Lausanne). 2022 Jan 11;8:798130
pubmed: 35087848
Virus Evol. 2021 Jul 30;7(2):veab064
pubmed: 34527285
Biotechniques. 2002 Dec;33(6):1210-2, 1214
pubmed: 12503300
J Virol Methods. 2022 Jun;304:114512
pubmed: 35257682
PLoS One. 2021 Dec 14;16(12):e0260850
pubmed: 34905589
Microb Genom. 2020 Mar;6(3):
pubmed: 32065578
J Virol Methods. 2023 Feb;312:114648
pubmed: 36368344
Signal Transduct Target Ther. 2022 Apr 26;7(1):138
pubmed: 35474215
Appl Transl Genom. 2016 Mar 10;9:15-9
pubmed: 27354935
Front Genet. 2021 Jul 28;12:711437
pubmed: 34394197
Biol Methods Protoc. 2020 Jul 18;5(1):bpaa014
pubmed: 33029559
Nat Rev Genet. 2022 Sep;23(9):547-562
pubmed: 35459859
Nat Protoc. 2017 Jun;12(6):1261-1276
pubmed: 28538739
Gigascience. 2021 Feb 16;10(2):
pubmed: 33590861
Nat Microbiol. 2022 Aug;7(8):1161-1179
pubmed: 35798890
Emerg Infect Dis. 2021 Nov;27(11):2957-2960
pubmed: 34437831
Influenza Other Respir Viruses. 2021 Nov;15(6):707-710
pubmed: 34346163
Euro Surveill. 2017 Mar 30;22(13):
pubmed: 28382917
Nat Microbiol. 2021 Jul;6(7):821-823
pubmed: 34108654
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794443
Rand Health Q. 2022 Aug 31;9(4):24
pubmed: 36238008
Sci Rep. 2022 Feb 14;12(1):2419
pubmed: 35165301
Sci Rep. 2021 Aug 5;11(1):15869
pubmed: 34354202
PLoS One. 2022 Jan 20;17(1):e0262170
pubmed: 35051202
Cell. 2020 Apr 16;181(2):271-280.e8
pubmed: 32142651
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
Brief Bioinform. 2021 Mar 22;22(2):616-630
pubmed: 33279989
Nature. 2020 Mar;579(7798):265-269
pubmed: 32015508
BMC Genomics. 2022 Feb 11;23(1):121
pubmed: 35148677